Moreover, increases in YKL-40 were linked to a lower survival rate in grade 3 gliomas (HR = 1.4, p = 0.0001) and glioblastomas (HR = 1.4, p < 0.0001). The gene discussed is CHI3L1; the disease is central nervous system cancer.